ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 9 8 2019
medline: 19 3 2020
entrez: 9 8 2019
Statut: ppublish

Résumé

ApoC-III (apolipoprotein C-III) glycosylation can predict cardiovascular disease risk. Higher abundance of disialylated (apoC-III Our results indicate that HSPGs preferentially clear apoC-III

Identifiants

pubmed: 31390883
doi: 10.1161/ATVBAHA.119.312723
pmc: PMC6761044
mid: NIHMS1535794
doi:

Substances chimiques

Apolipoprotein C-III 0
ISIS 304801 0
Lipoproteins, HDL3 0
Oligonucleotides 0
Receptors, LDL 0

Types de publication

Clinical Trial, Phase II Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2145-2156

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK082542
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD089067
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM033063
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054434
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG055770
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001855
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG056518
Pays : United States
Organisme : NIDDK NIH HHS
ID : R24 DK090958
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000130
Pays : United States

Références

J Biol Chem. 2000 Nov 3;275(44):34459-64
pubmed: 10921925
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):853-8
pubmed: 12637336
J Lipid Res. 2006 Jun;47(6):1212-8
pubmed: 16495512
J Clin Invest. 2007 Jan;117(1):153-64
pubmed: 17200715
J Lipid Res. 2007 May;48(5):1190-203
pubmed: 17314277
Science. 2008 Dec 12;322(5908):1702-5
pubmed: 19074352
Diabetes. 2009 Sep;58(9):2018-26
pubmed: 19502413
J Lipid Res. 2010 Jan;51(1):150-61
pubmed: 19622837
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):239-45
pubmed: 19910636
Circulation. 2010 Apr 20;121(15):1722-34
pubmed: 20368524
Curr Opin Lipidol. 2010 Jun;21(3):218-28
pubmed: 20463470
J Biol Chem. 2010 Dec 3;285(49):37976-86
pubmed: 20852327
Biochim Biophys Acta. 1978 Jun 15;541(2):234-40
pubmed: 208636
Curr Opin Lipidol. 2012 Jun;23(3):206-12
pubmed: 22510806
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9893-8
pubmed: 22566642
Cardiovasc Hematol Disord Drug Targets. 2012 Dec;12(2):133-40
pubmed: 23030451
Eur Heart J. 2013 Jun;34(24):1826-33
pubmed: 23248205
J Biol Chem. 1990 Jun 25;265(18):10771-9
pubmed: 2355022
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2065-74
pubmed: 23846497
N Engl J Med. 2014 Jul 3;371(1):22-31
pubmed: 24941081
N Engl J Med. 2014 Jul 3;371(1):32-41
pubmed: 24941082
Lancet. 2014 Aug 16;384(9943):626-635
pubmed: 25131982
N Engl J Med. 2014 Dec 4;371(23):2200-6
pubmed: 25470695
N Engl J Med. 2015 Jul 30;373(5):438-47
pubmed: 26222559
PLoS One. 2015 Dec 03;10(12):e0144138
pubmed: 26633899
J Lipid Res. 2016 May;57(5):894-905
pubmed: 26945091
Curr Cardiol Rep. 2016 Jul;18(7):67
pubmed: 27216847
J Clin Invest. 2016 Aug 1;126(8):2855-66
pubmed: 27400128
Cell Metab. 2016 Aug 9;24(2):234-45
pubmed: 27508872
J Clin Lipidol. 2017 Jan - Feb;11(1):224-233.e2
pubmed: 28391889
Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1206-1212
pubmed: 28473441
Curr Opin Lipidol. 2018 Jun;29(3):171-179
pubmed: 29547399
Matrix Biol. 2018 Oct;71-72:262-282
pubmed: 29803939
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):63-72
pubmed: 30580564
J Clin Invest. 1986 Nov;78(5):1287-95
pubmed: 3095375
J Lipid Res. 2019 Aug;60(8):1379-1395
pubmed: 31092690
J Biol Chem. 1988 Dec 5;263(34):17925-32
pubmed: 3192519
J Lipid Res. 1985 May;26(5):556-65
pubmed: 4020294
J Biol Chem. 1974 Aug 10;249(15):4975-84
pubmed: 4846755
Biochem Biophys Res Commun. 1972 Jan 31;46(2):375-82
pubmed: 5057882
N Engl J Med. 1982 Jun 24;306(25):1513-9
pubmed: 7078608
J Lipid Res. 1981 Nov;22(8):1235-46
pubmed: 7320634
J Biol Chem. 1995 Dec 1;270(48):28767-76
pubmed: 7499399
J Lipid Res. 1997 Jul;38(7):1421-32
pubmed: 9254067
J Biol Chem. 1997 Dec 12;272(50):31348-54
pubmed: 9395464

Auteurs

Natalie C Kegulian (NC)

From the Department of Medicine, University of Southern California, Los Angeles (N.C.K., S.H., H.N.Y.).

Bastian Ramms (B)

Department of Medicine (B.R., J.D.E., P.L.S.M.G.), University of California San Diego, La Jolla.
Department of Chemistry, Biochemistry I, Bielefeld University, Germany (B.R.).

Steven Horton (S)

From the Department of Medicine, University of Southern California, Los Angeles (N.C.K., S.H., H.N.Y.).

Olgica Trenchevska (O)

The Biodesign Institute, Arizona State University, Tempe (O.T., D.N.).

Dobrin Nedelkov (D)

The Biodesign Institute, Arizona State University, Tempe (O.T., D.N.).

Mark J Graham (MJ)

Ionis Pharmaceuticals, Carlsbad, CA (M.J.G., R.G.L.).

Richard G Lee (RG)

Ionis Pharmaceuticals, Carlsbad, CA (M.J.G., R.G.L.).

Jeffrey D Esko (JD)

Department of Medicine (B.R., J.D.E., P.L.S.M.G.), University of California San Diego, La Jolla.
Glycobiology Research and Training Center (J.D.E., P.L.S.M.G.), University of California San Diego, La Jolla.

Hussein N Yassine (HN)

From the Department of Medicine, University of Southern California, Los Angeles (N.C.K., S.H., H.N.Y.).

Philip L S M Gordts (PLSM)

Department of Medicine (B.R., J.D.E., P.L.S.M.G.), University of California San Diego, La Jolla.
Glycobiology Research and Training Center (J.D.E., P.L.S.M.G.), University of California San Diego, La Jolla.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH